Table Of Content:
CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
1.1.1. Definition of Drug Delivery Devices
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Drug Delivery Devices Market By Route of Administration
1.2.2.1. Global Drug Delivery Devices Market Revenue and Growth Rate Comparison By Route of Administration(2020-2027)
1.2.2.2. Global Drug Delivery Devices Market Revenue Share By Route of Administration in 2019
1.2.2.3. Inhalation
1.2.2.4. Topical
1.2.2.5. Injection
1.2.2.6. Transmucosal
1.2.3. Drug Delivery Devices Market By Patient Care Setting
1.2.3.1. Global Drug Delivery Devices Market Revenue and Growth Rate Comparison By Patient Care Setting (2020-2027)
1.2.3.2. Global Drug Delivery Devices Market Revenue Share By Patient Care Setting in 2019
1.2.3.2.1. Diagnostic Centers
1.2.3.2.2. Home Care Settings
1.2.3.2.3. Hospitals
1.2.3.2.4. Ambulatory Surgery Centers/Clinics
1.2.3.2.5. Others
1.2.4. Drug Delivery Devices Market By Application
1.2.4.1. Global Drug Delivery Devices Market Revenue and Growth Rate Comparison By Application(2020-2027)
1.2.4.2. Global Drug Delivery Devices Market Revenue Share By Application in 2019
1.2.4.2.1. Infectious Diseases
1.2.4.2.2. Cancer
1.2.4.2.3. Respiratory Diseases
1.2.4.2.4. Cardiovascular Diseases
1.2.4.2.5. Central Nervous System Disorders
1.2.4.2.6. Diabetes
1.2.4.2.7. Autoimmune Diseases
1.2.4.2.8. Others
1.2.5. Drug Delivery Devices Market By Geography
1.2.5.1. Global Drug Delivery Devices Market Revenue and Growth Rate Comparison by Geography (2020-2027)
1.2.5.2. North America Drug Delivery Devices Market Revenue and Growth Rate(2020-2027)
1.2.5.3. Europe Drug Delivery Devices Market Revenue and Growth Rate(2020-2027)
1.2.5.4. Asia-Pacific Drug Delivery Devices Market Revenue and Growth Rate(2020-2027)
1.2.5.5. Latin America Drug Delivery Devices Market Revenue and Growth Rate(2020-2027)
1.2.5.6. Middle East and Africa (MEA) Drug Delivery Devices Market Revenue and Growth Rate(2020-2027)
CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2019
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players
CHAPTER 3. MANUFACTURING Drug Delivery Devices ANALYSIS
3.1. Capacity and Commercial Production Date of Global Drug Delivery Devices Major Manufacturers in 2019
3.2. Manufacturing Plants Distribution of Global Drug Delivery Devices Major Manufacturers in 2019
3.3. R&D Status and Manufacturing End-User of Global Drug Delivery Devices Major Manufacturers in 2019
3.4. Raw Materials End-Users Analysis of Global Drug Delivery Devices Major Manufacturers in 2019
CHAPTER 4. Drug Delivery Devices MARKET By Route of Administration
4.1. Global Drug Delivery Devices Revenue By Route of Administration
4.2. Inhalation
4.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.3. Topical
4.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.4. Injection
4.4.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
4.5. Transmucosal
4.5.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
CHAPTER 5. Drug Delivery Devices MARKET By Patient Care Setting
5.1. Global Drug Delivery Devices Revenue By Patient Care Setting
5.2. Diagnostic Centers
5.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
5.3. Home Care Settings
5.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
5.4. Hospitals
5.4.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
5.5. Ambulatory Surgery Centers/Clinics
5.5.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
5.6. Others
5.6.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
CHAPTER 6. Drug Delivery Devices MARKET By Application
6.1. Global Drug Delivery Devices Revenue By Application
6.2. Infectious Diseases
6.2.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.3. Cancer
6.3.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.4. Respiratory Diseases
6.4.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.5. Cardiovascular Diseases
6.5.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.5.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.6. Central Nervous System Disorders
6.6.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.6.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.7. Diabetes
6.7.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.7.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.8. Autoimmune Diseases
6.8.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.8.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
6.9. Others
6.9.1. Market Revenue and Growth Rate, 2020 - 2027 ($Million)
6.9.2. Market Revenue and Forecast, By Region, 2020 - 2027 ($Million)
CHAPTER 7. NORTH AMERICA Drug Delivery Devices MARKET BY COUNTRY
7.1. North America Drug Delivery Devices Market Revenue and Growth Rate, 2020 - 2027 ($Million)
7.2. North America Drug Delivery Devices Market Revenue Share Comparison, 2020 & 2027 (%)
7.3. U.S.
7.3.1. U.S. Drug Delivery Devices Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
7.3.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
7.3.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
7.4.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
7.4.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
CHAPTER 8. EUROPE SMART REFRIGERATOR MARKET BY COUNTRY
8.1. Europe Drug Delivery Devices Market Revenue and Growth Rate, 2020 - 2027 ($Million)
8.2. Europe Drug Delivery Devices Market Revenue Share Comparison, 2020 & 2027 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
8.3.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
8.3.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
8.4.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
8.4.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
8.5.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
8.5.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
8.6.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
8.6.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
8.7.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
8.7.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
CHAPTER 9. ASIA-PACIFIC Drug Delivery Devices MARKET BY COUNTRY
9.1. Asia-Pacific Drug Delivery Devices Market Revenue and Growth Rate, 2020 - 2027 ($Million)
9.2. Asia-Pacific Drug Delivery Devices Market Revenue Share Comparison, 2020 & 2027 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
9.3.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
9.3.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
9.4.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
9.4.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
9.5.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
9.5.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
9.6.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
9.6.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
9.7.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
9.7.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
9.8.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
9.8.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
CHAPTER 10. LATIN AMERICA Drug Delivery Devices MARKET BY COUNTRY
10.1. Latin America Drug Delivery Devices Market Revenue and Growth Rate, 2020 - 2027 ($Million)
10.2. Latin America Drug Delivery Devices Market Revenue Share Comparison, 2020 & 2027 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
10.3.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
10.3.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
10.4. Mexico
10.4.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
10.4.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
10.4.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
10.5.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
10.5.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
CHAPTER 11. MIDDLE EAST & AFRICA Drug Delivery Devices MARKET BY COUNTRY
11.1. Middle East & Africa Drug Delivery Devices Market Revenue and Growth Rate, 2020 - 2027 ($Million)
11.2. Middle East & Africa Drug Delivery Devices Market Revenue Share Comparison, 2020 & 2027 (%)
11.3. GCC
11.3.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
11.3.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
11.3.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
11.4. South Africa
11.4.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
11.4.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
11.4.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
11.5. Rest of Middle East & Africa
11.5.1. Market Revenue and Forecast By Route of Administration, 2020 - 2027 ($Million)
11.5.2. Market Revenue and Forecast By Patient Care Setting, 2020 - 2027 ($Million)
11.5.3. Market Revenue and Forecast By Application, 2020 - 2027 ($Million)
CHAPTER 12. COMPANY PROFILE
12.1. B. Braun Melsungen AG
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. 3M
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Abbott Laboratories
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Pfizer, Inc.
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Baxter International Inc.
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Smith Medical
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. F. Hoffmann-La Roche Ltd.
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. CareFusion Corporation
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Others
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope
Growth in the consumption of drugs and therapeutic pharmaceuticals is a key driver of the market.
Increase in complications and expertise required in delivering drugs.
The market value of drug delivery devices is anticipated to be around US$ 2.8 Bn in 2027.
It is anticipated to grow around 6.2% CAGR amid the forecast period 2020-2027.
The key players operating in drug delivery devices market such as B. Braun Melsungen AG, 3M, Abbott Laboratories, Pfizer, Inc., Baxter International Inc., Smith Medical, F. Hoffmann-La Roche Ltd., CareFusion Corporation, and Others.
Asia Pacific is projected to grow at a fast pace during forecast period 2020-2027.
North America held maximum share in 2019.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date